NasdaqCM:LLIT

Stock Analysis Report

Executive Summary

Lianluo Smart Limited, through its subsidiaries, designs, develops, markets, and distributes medical products and medical components primarily in China and internationally.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.


Similar Companies

Share Price & News

How has Lianluo Smart's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-13.3%

LLIT

-0.003%

US Medical Equipment

1.3%

US Market


1 Year Return

-62.4%

LLIT

11.9%

US Medical Equipment

5.9%

US Market

Return vs Industry: LLIT underperformed the US Medical Equipment industry which returned 11.9% over the past year.

Return vs Market: LLIT underperformed the US Market which returned 5.9% over the past year.


Shareholder returns

LLITIndustryMarket
7 Day-13.3%-0.003%1.3%
30 Day-14.5%-3.0%-1.9%
90 Day-31.6%-0.6%-1.8%
1 Year-62.4%-62.4%12.8%11.9%8.3%5.9%
3 Year-58.1%-58.1%69.6%64.5%45.6%36.2%
5 Year-86.7%-86.7%129.6%104.0%66.1%47.9%

Price Volatility Vs. Market

How volatile is Lianluo Smart's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Lianluo Smart undervalued compared to its fair value and its price relative to the market?

3.71x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate LLIT's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate LLIT's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: LLIT is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: LLIT is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate LLIT's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: LLIT is overvalued based on its PB Ratio (3.7x) compared to the US Medical Equipment industry average (3.6x).


Next Steps

Future Growth

How is Lianluo Smart forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.4%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Lianluo Smart has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Lianluo Smart performed over the past 5 years?

-32.3%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: LLIT is unprofitable, and losses have increased over the past 5 years at a rate of -32.3% per year.

Accelerating Growth: Unable to compare LLIT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LLIT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (28.2%).


Return on Equity

High ROE: LLIT has a negative Return on Equity (-285.89%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: LLIT is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: LLIT is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Lianluo Smart's financial position?


Financial Position Analysis

Short Term Liabilities: LLIT's short term assets ($2.7M) exceeds its short term liabilities ($1.5M)

Long Term Liabilities: LLIT's short term assets (2.7M) exceeds its long term liabilities (1.1M)


Debt to Equity History and Analysis

Debt Level: LLIT is debt free.

Reducing Debt: LLIT has no debt compared to 5 years ago when its debt to equity ratio was 6.6%.


Balance Sheet

Inventory Level: LLIT has a high level of physical assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if LLIT's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if LLIT has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if LLIT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Lianluo Smart's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate LLIT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate LLIT's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if LLIT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if LLIT's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of LLIT's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Lianluo Smart's salary, the management and board of directors tenure and is there insider trading?

8.3yrs

Average management tenure


CEO

Ping Chen (56yo)

19.8yrs

Tenure

US$31,256

Compensation

Mr. Ping Chen has been the Chief Executive Officer of Lianluo Smart Ltd since 2000 and serves its General Manager and Director since 2003. Mr. Ping served as the Chief Executive Officer of Beijing Chengche ...


CEO Compensation Analysis

Compensation vs. Market: Ping's total compensation ($USD31.26K) is too low to compare against companies of similar size in the US market ($USD495.77K).

Compensation vs Earnings: Ping's compensation has increased whilst the company is unprofitable.


Management Age and Tenure

8.3yrs

Average Tenure

Experienced Management: LLIT's management team is seasoned and experienced (8.3 years average tenure).


Board Age and Tenure

3.0yrs

Average Tenure

47yo

Average Age

Experienced Board: LLIT's board of directors are considered experienced (3 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Ping Chen (56yo)

    CEO, GM & Director

    • Tenure: 19.8yrs
    • Compensation: US$31.26k
  • Janice Wang

    Chief Technology Officer

    • Tenure: 8.3yrs
  • Lisa Zhou

    Investor Relations Manager

    • Tenure: 0yrs
  • Li Sun

    Vice President and Director of Sales

    • Tenure: 0yrs
  • Fei Dong

    Director of Operations

    • Tenure: 0yrs
  • Yingmei Yang (48yo)

    Interim Chief Financial Officer

    • Tenure: 1.6yrs

Board Members

  • Ping Chen (56yo)

    CEO, GM & Director

    • Tenure: 19.8yrs
    • Compensation: US$31.26k
  • Zhitao He (37yo)

    Chairman

    • Tenure: 3yrs
  • Bin Pan (47yo)

    Independent Director

    • Tenure: 3yrs
    • Compensation: US$8.00k
  • Richard Chang (56yo)

    Independent Director

    • Tenure: 3yrs
    • Compensation: US$8.00k
  • Xiaogang Tong (39yo)

    Independent Director

    • Tenure: 1.2yrs
    • Compensation: US$4.00k

Company Information

Lianluo Smart Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Lianluo Smart Limited
  • Ticker: LLIT
  • Exchange: NasdaqCM
  • Founded: 2003
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$11.576m
  • Shares outstanding: 17.81m
  • Website: https://www.lianluosmart.com

Number of Employees


Location

  • Lianluo Smart Limited
  • China Railway Construction Building
  • 21st Floor
  • Beijing
  • 100040
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
LLITNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDApr 2010
J8DDB (Deutsche Boerse AG)YesCommon StockDEEURApr 2010

Biography

Lianluo Smart Limited, through its subsidiaries, designs, develops, markets, and distributes medical products and medical components primarily in China and internationally. The company offers medical devic ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/15 00:14
End of Day Share Price2019/10/11 00:00
Earnings2018/12/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.